RxDoctor Payments Data

Christopher Dinh

Rheumatology · Bellevue, WANPI 1811787484

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.5% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations.

$2,184in general payments, 2019–2025

Across 73 payments — averaging $29.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$404
  • Johnson & Johnson$374
  • UCB, Inc.$250
  • Janssen Scientific Affairs, LLC$197
  • AstraZeneca$156
  • Tersera Therapeutics LLC$112
  • plus $692 from 17 others

What the payments were for

  • Food & beverage$2,12997%
  • Education$553%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,184 in reported general payments places this provider in the 70th percentile of 157 rheumatology providers in Washington.

See all rheumatology providers in Washington

Other rheumatology in Bellevue

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →